Thomas J Farrell Net Worth & Insider Trades
Thomas J Farrell - President and CEO, Bellicum Pharmaceuticals, Inc
What is Thomas J Farrell's Net Worth?
The current estimated net worth of Bellicum Pharmaceuticals, Inc's President and CEO, Thomas J Farrell, is estimated to be about $160.85K . Thomas J Farrell owns about 63,862 units of Bellicum Pharmaceuticals, Inc common stock. In the last 3 years at Bellicum Pharmaceuticals, Inc, Thomas J Farrell has sold an estimated value of $128.99K worth.
What is Thomas J Farrell's Past Insider Trading?
Thomas J Farrell's largest sale order was 2,500 units , worth over $50.61K on August 5, 2015. In total, Thomas J Farrell has made about 7 transactions over 3 years of their time at Bellicum Pharmaceuticals, Inc. Thomas J Farrell usually trades in January, with the busiest year in 2015. The most recent transaction was a sale order of 2,500 units , worth over $36.44K on October 6, 2015.
Thomas J Farrell
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Thomas J Farrell's' Mailing Address?
- Mailing address is C/o Bellicum Pharmaceuticals, Inc. 2130 W. Holcombe Blvd., Ste. 800 Houston TX 77030 TX
Bellicum Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Richard A. Fair, | 2020 | $625,910 | - | $1,786,412 | $249,190 | $21,433 | $2,682,945 |
| Richard A. Fair, | 2019 | $566,204 | - | $1,021,004 | $127,990 | $17,690 | $1,732,888 |
| Atabak Mokari, | 2020 | $408,373 | $163,764 | $542,889 | - | $536,708 | $1,651,734 |
| Atabak Mokari, | 2019 | $375,000 | - | $669,168 | $61,500 | $2,233 | $1,107,901 |
| Shane M. Ward, | 2020 | $407,752 | $164,114 | $412,193 | - | $552,275 | $1,536,334 |
| Shane M. Ward, | 2019 | $374,062 | - | $153,151 | $61,705 | $17,941 | $606,859 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1358403/000119312521141608/d176237ddef14a.htm
What are Bellicum Pharmaceuticals, Inc's Past Insider Trades?
Bellicum Pharmaceuticals, Inc's most recent insider trade came on March 19, 2020 by Richard A Fair who bought 5,000 units worth $20K . In the last 5 years, insiders at Bellicum Pharmaceuticals, Inc have sold an estimated value of $18.67M and bought an estimated value of $2.85M worth of shares. Insider trading is most common in June, with the busiest year in 2016. The most active traders at the company are David Spencer, Chief Technology Officer, Kevin Slawin, Director, and Alan A Musso, CFO and Treasurer .
BELLICUM PHARMACEUTICALS, INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||